Data show unresectable patients becoming eligible for surgery
Personalised cancer vaccine with immunotherapy reduces melanoma recurrence after surgery
AI drug choices may cost millions
Researchers reprogramme pancreatic cancer tumour microenvironment
‘Positive trends’ from phase 2 amyotrophic lateral sclerosis trial
Successful results from trial of first-in-class Parkinson’s disease peptide
Researchers uncover how neurons deliver RNA where it is needed
Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
Antibody targeting TSLP achieves positive results in asthma study